Anne-flore Plane
Caen, 14000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Improvement of cardiac function by Ivabradine in a doxorubicin-induced cardiomyopathy murine model is associated with a normal renal angiotensin II type I receptor expression but not with a reduction in fibrosis.
Journal: Cardio-oncology (London, England)
Published: October 15, 2025
Association Between the Renin-Angiotensin System and Ibrutinib-Related Cardiovascular Adverse Events: A Translational Cohort Study.
Journal: Biomedicines
Published: June 04, 2025
Identification of anticancer drugs associated to cancer therapy-related cardiac dysfunction: a VigiBase® disproportionality analysis.
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: February 17, 2025
Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysis.
Journal: European heart journal
Published: March 19, 2021
Identification of anticancer drugs associated with atrial fibrillation: analysis of the WHO pharmacovigilance database.
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: January 11, 2020
Cardiovascular safety of rapidly accelerated fibrosarcoma B-type and/or mitogen-activated extracellular signal-regulated kinase inhibitors: A mixed approach combining a meta-analysis and a pharmacovigilance disproportionality analysis.
Journal: Archives of cardiovascular diseases
Published: December 09, 2019
Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors.
Journal: Journal for immunotherapy of cancer
Published: November 18, 2019
Life-threatening hyperkalaemia after succinylcholine - Authors' reply.
Journal: Lancet (London, England)
Published: August 13, 2019
Occluded or Not?: A Subtle Electrocardiographic Answer.
Journal: JACC. Case reports
Published: May 01, 2019
Last Updated: 09/26/2026